A second look at the status quo for secondary acute myeloid leukemia after hypomethylating agents is a research paper published in Cancer (2025). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
National Institute of General Medical Sciences
Grant: T32GM086330
Fields of Study
Keywords
Sustainable Development Goals